LIVE

Serial Number

98148761

Owner

Tisento Therapeutics Inc.

Attorney

Anessa O. Kramer

First Use Date

Jul 28, 2025

Filing Date

Aug 24, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

Serial #98148761 Trademark

Serial Number: 98148761 • Registration: 8232957

Serial #98148761 is a trademark filed by Tisento Therapeutics Inc. on August 24, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Tisento Therapeutics Inc. (6 trademarks)

Riverview II, 18th Floor
Cambridge, MA 02142

Entity Type: 03

Legal Representation

Attorney of Record

Anessa O. Kramer

348 trademarks filed View all →

Correspondence Address

Anessa O. Kramer Honigman LLP

39400 Woodward Avenue, Suite 101

Bloomfield Hills, MI 48304-5151

United States

Trademark Details

Filing Date

August 24, 2023

Registration Date

April 28, 2026

First Use Anywhere

July 28, 2025

First Use in Commerce

July 28, 2025

Published for Opposition

November 12, 2024

Goods & Services

Pharmaceutical preparations for the treatment of mitochondrial diseases or disorders

Pharmaceutical research and development; Conducting pharmaceutical clinical trials for others in the field of mitochondrial disease; Pharmaceutical product development

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 28, 2026 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 28, 2026 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 9, 2026 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 9, 2026 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Apr 8, 2026 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 7, 2026 AITU

USE AMENDMENT FILED

Oct 17, 2025 IUAF

TEAS STATEMENT OF USE RECEIVED

Oct 17, 2025 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 15, 2025 EXRA

SOU EXTENSION 1 GRANTED

Jun 11, 2025 EX1G

SOU EXTENSION 1 FILED

Jun 11, 2025 EXT1

SOU TEAS EXTENSION RECEIVED

Jun 11, 2025 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 24, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 12, 2024 NPUB

PUBLISHED FOR OPPOSITION

Nov 12, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 23, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 30, 2024 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 24, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 24, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 24, 2024 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 26, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 26, 2024 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 29, 2024 GNRN

NON-FINAL ACTION E-MAILED

Mar 29, 2024 GNRT

NON-FINAL ACTION WRITTEN

Mar 29, 2024 CNRT

ASSIGNED TO EXAMINER

Mar 18, 2024 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Sep 26, 2023 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 25, 2023 NWOS

NEW APPLICATION ENTERED

Aug 28, 2023 NWAP

Related Trademarks

More from this Owner

TISENTO THERAPEUTICS

More in Same Class

BIOCON BIOLOGICS TRANSFORMING HEALTHCARE. TRANSFORMING LIVES.

LYTESUP

IZERVAY

OSMOVIR

CAPLIN POINT LABORATORIES